These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 25878131)

  • 1. Evaluating the potential impact of enhancing HIV treatment and tuberculosis control programmes on the burden of tuberculosis.
    Chindelevitch L; Menzies NA; Pretorius C; Stover J; Salomon JA; Cohen T
    J R Soc Interface; 2015 May; 12(106):. PubMed ID: 25878131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential effects of changing HIV treatment policy on tuberculosis outcomes in South Africa: results from three tuberculosis-HIV transmission models.
    Pretorius C; Menzies NA; Chindelevitch L; Cohen T; Cori A; Eaton JW; Fraser C; Gopalappa C; Hallett TB; Salomon JA; Stover J; White RG; Dodd PJ
    AIDS; 2014 Jan; 28 Suppl 1():S25-34. PubMed ID: 24468944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tuberculosis associated mortality in a prospective cohort in Sub Saharan Africa: Association with HIV and antiretroviral therapy.
    Nagu TJ; Aboud S; Mwiru R; Matee MI; Rao M; Fawzi WW; Zumla A; Maeurer MJ; Mugusi F
    Int J Infect Dis; 2017 Mar; 56():39-44. PubMed ID: 28161460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting the long-term impact of antiretroviral therapy scale-up on population incidence of tuberculosis.
    Dodd PJ; Knight GM; Lawn SD; Corbett EL; White RG
    PLoS One; 2013; 8(9):e75466. PubMed ID: 24069418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tuberculosis and HIV interaction in sub-Saharan Africa: impact on patients and programmes; implications for policies.
    Maher D; Harries A; Getahun H
    Trop Med Int Health; 2005 Aug; 10(8):734-42. PubMed ID: 16045459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reducing deaths from tuberculosis in antiretroviral treatment programmes in sub-Saharan Africa.
    Lawn SD; Harries AD; Meintjes G; Getahun H; Havlir DV; Wood R
    AIDS; 2012 Nov; 26(17):2121-33. PubMed ID: 22695302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiretroviral drugs for tuberculosis control in the era of HIV/AIDS.
    Williams BG; Dye C
    Science; 2003 Sep; 301(5639):1535-7. PubMed ID: 12920302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoprophylaxis for tuberculosis in HIV-infected individuals in sub-Saharan Africa.
    Nuwaha F
    East Afr Med J; 1998 Sep; 75(9):520-7. PubMed ID: 10493054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of tuberculosis diagnostic strategies to reduce early mortality among persons with advanced HIV infection initiating antiretroviral therapy.
    Abimbola TO; Marston BJ; Date AA; Blandford JM; Sangrujee N; Wiktor SZ
    J Acquir Immune Defic Syndr; 2012 May; 60(1):e1-7. PubMed ID: 22240465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control.
    Lawn SD; Myer L; Bekker LG; Wood R
    AIDS; 2006 Aug; 20(12):1605-12. PubMed ID: 16868441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the impact of antiretroviral therapy on tuberculosis notification rates among people with HIV: a descriptive analysis of 23 countries in sub-Saharan Africa, 2010-2015.
    Surie D; Borgdorff MW; Cain KP; Click ES; DeCock KM; Yuen CM
    BMC Infect Dis; 2018 Sep; 18(1):481. PubMed ID: 30257667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highly active antiretroviral therapy and tuberculosis control in Africa: synergies and potential.
    Harries AD; Hargreaves NJ; Chimzizi R; Salaniponi FM
    Bull World Health Organ; 2002; 80(6):464-9. PubMed ID: 12132003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa.
    Eaton JW; Johnson LF; Salomon JA; Bärnighausen T; Bendavid E; Bershteyn A; Bloom DE; Cambiano V; Fraser C; Hontelez JA; Humair S; Klein DJ; Long EF; Phillips AN; Pretorius C; Stover J; Wenger EA; Williams BG; Hallett TB
    PLoS Med; 2012; 9(7):e1001245. PubMed ID: 22802730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A clinical and epidemiologic update on the interaction between tuberculosis and human immunodeficiency virus infection in adults.
    Habib AG
    Ann Afr Med; 2009; 8(3):147-55. PubMed ID: 19884690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential utility of empirical tuberculosis treatment for HIV-infected patients with advanced immunodeficiency in high TB-HIV burden settings.
    Lawn SD; Ayles H; Egwaga S; Williams B; Mukadi YD; Santos Filho ED; Godfrey-Faussett P; Granich RM; Harries AD
    Int J Tuberc Lung Dis; 2011 Mar; 15(3):287-95. PubMed ID: 21333094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential impact of enhanced diagnostic techniques for tuberculosis driven by HIV: a mathematical model.
    Dowdy DW; Chaisson RE; Moulton LH; Dorman SE
    AIDS; 2006 Mar; 20(5):751-62. PubMed ID: 16514306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress and prospects for the control of HIV and tuberculosis in South Africa: a dynamical modelling study.
    Williams BG; Gupta S; Wollmers M; Granich R
    Lancet Public Health; 2017 May; 2(5):e223-e230. PubMed ID: 29253488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tuberculosis in sub-Saharan Africa: a regional assessment of the impact of the human immunodeficiency virus and National Tuberculosis Control Program quality.
    Cantwell MF; Binkin NJ
    Tuber Lung Dis; 1996 Jun; 77(3):220-5. PubMed ID: 8758104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of mortality in adults on treatment for human immunodeficiency virus-associated tuberculosis in Botswana: A retrospective cohort study.
    Muyaya LM; Young T; Loveday M
    Medicine (Baltimore); 2018 Apr; 97(16):e0486. PubMed ID: 29668628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling the implementation of population-level isoniazid preventive therapy for tuberculosis control in a high HIV-prevalence setting.
    Rhines AS; Feldman MW; Bendavid E
    AIDS; 2018 Sep; 32(15):2129-2140. PubMed ID: 30096067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.